Second, post-marketing data reveal that real-world adherence and persistence are lower than in clinical trials, often due to gastrointestinal side effects, treatment fatigue, or cost-related barriers (143145)
Archived from the original on 20 March 2011
Patients should always inform their healthcare providers about any medications theyre on
The legal battle over GLP-1 medications like Ozempic, Mounjaro, and Wegovy is heating up as plaintiffs push back against attempts to dismiss the bulk of their claims
We performed a frequentist network meta-analysis to measure network estimates for the relative outcomes
Tirzepatide, another glucose-lowering medication known by the brand name Mounjaro, was approved for diabetes treatment in 2022 and is under fast-track review for weight loss